Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease.
Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Parlongo S, Cutrupi S, Iellamo D, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Malatino LS.
Zoccali C, et al. Among authors: cataliotti a.
J Am Soc Nephrol. 2003 Oct;14(10):2611-7. doi: 10.1097/01.asn.0000089026.28617.33.
J Am Soc Nephrol. 2003.
PMID: 14514739